Oct.05 — Guardant Health Inc., a cancer-detection firm backed by SoftBank Group Corp., raised $237.5 million in its U.S. initial public offering. Bloomberg’s Alex Barinka talks with Helmy Eltoukhy, chief executive officer and co-founder of Guardant, about the company’s business model and growth opportunities.
source
Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.
This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.